OriCiro is focused on the development and commercialization of cell-free synthesis and amplification technology of genome-scale large DNA for applications in gene and cell-based therapies and synthetic biolog
Location: Japan, Tokyo
Total raised: $9.15M
Founded date: 2018
Investors 3
| Date | Name | Website |
| - | Unreasonab... | unreasonab... |
| - | ITOCHU Tec... | techv.co.j... |
| 10.07.2026 | The Univer... | ut-ec.co.j... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.08.2021 | Series B | $9.15M | - |
Mentions in press and media 8
| Date | Title | Description |
| 06.06.2022 | OriCiro Announces Series B2 Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology | TOKYO, June 6, 2022 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has closed Series B2 financing from Asahi... |
| 18.05.2022 | OriCiro Genomics expand into Boston, Open new office in North America | TOKYO, May 18, 2022 /PRNewswire/ -- OriCiro Genomics K.K. a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapeutics and synthetic biology, today announced the open US office in North America. In ... |
| 29.11.2021 | OriCiro Genomics Launches New enzymatic DNA synthesis tool for commonly used vectors | TOKYO, Nov. 29, 2021 /PRNewswire/ -- OriCiro Genomics Inc., a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapeutics and synthetic biology, today announced the launch of OriCiro® Cell-Free Switc... |
| 23.07.2021 | OriCiro Genomics Raises ¥800M in Series B Financing | OriCiro Genomics, a Tokyo, Japan-based pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, raised ¥800m in Series B financing. The round was led by The University of Tokyo E... |
| 20.07.2021 | OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology | TOKYO, July 20, 2021 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B fina... |
| 20.07.2021 | OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology | TOKYO, July 20, 2021 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B fina... |
| 20.07.2021 | OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology | |
| 30.09.2020 | OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNA |